Treatment of pulmonic regurgitation may be divided into medical and surgical treatment. Medical management of pulmonic regurgitation may include use of diuretics in patients with RV dysfunction. ACE inhibitors and B blockers may be used to reverse neurohormonal activation and improve symptoms. Antibiotic prophylaxis may be indicated in certain conditions such as patients with cyanotic heart disease, prosthetic heart valves, rheumatic heart disease, and patients previously having sustained bacterial endocarditis.
There are no specific medical measures for management of PR.
Diuretics are recommended in patients with RV dysfunction for maintenance of fluid balance.
In patients with repaired tetralogy of fallot, ACE inhibitors or beta-blockers are used to reverse the neuroharmonal activation and improve the symptoms.
Antiobiotic prophylaxis
The American Heart Association Recommendations on Prevention of Bacterial Endocarditis indicate that antibiotic prophylaxis is not necessary for pulmonic regurgitation in those patients with otherwise structurally normal pulmonic valves, particularly if there is no diastolic murmur. It should be noted, though, that those patients with the following conditions may warrant antibiotic prophylaxis:
Pulmonic regurgitation medical therapy
Pulmonary regurgitation medical therapy
Tricuspid stenosis medical therapy
Pulmonary regurgitation surgical therapy
Tricuspid regurgitation medical therapy
Pulmonic regurgitation treatment
Mitral stenosis medical therapy
Hypertrophic cardiomyopathy medical treatment